Orion Pharma, which opened a hub at Babraham Research Campus earlier this year, has already recruited more than 20 ...

Neuroscience company NRG Therapeutics, based at Stevenage Bioscience Catalyst, has followed its recent £50 million Series B ...

The East of England attracted £785.1million in venture capital investment in Q3 2025 - double the value of the previous quarter, according to the latest KPMG Private Enterprise Venture Pulse report.

Mishcon de Reya client Thom Browne, Inc has successfully defended Court of Appeal proceedings brought by adidas in relation to the validity of adidas’ 'three-stripe' trade marks.

A project which researches the optimum low energy extraction method needed to process cultivated kelp, resulting in soil ...

Executives of Oxbridge companies Darktrace, Oxford Nanopore and Oxford Science Enterprises today accompanied Chancellor ...

The number of new UK technology incorporations in the East of England soared to another record high in Q3 2025, as the sector ...

Accountancy and business adviser Larking Gowen acted as sell-side advisor to Dynamic Fluid Solutions Limited (DFS) in its ...

Pharmaceutical investment in the United Kingdom is approaching an inflection point, as decades of scientific strength are ...

Emmi Nicholl has just been promoted to CEO at Cambridge Angels. Tony Quested posed some key questions. How long have you been ...

Cambridge headquartered biopharma company AstraZeneca has invested $445 million in an upgraded manufacturing base in Texas.

A pre-Budget £500m investment by the Treasury allied to fresh alliances for the University with key bodies in Hong Kong and ...